Atherosclerosis

Papers
(The H4-Index of Atherosclerosis is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Endothelial dysfunction in COVID-19: Current findings and therapeutic implications215
Systemic immune-inflammation index and incident cardiovascular diseases among middle-aged and elderly Chinese adults: The Dongfeng-Tongji cohort study98
Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force89
Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene86
APOE gene variants in primary dyslipidemia78
Targeting HDAC6 attenuates nicotine-induced macrophage pyroptosis via NF-κB/NLRP3 pathway75
Carotid intima-media thickness should not be referred to as subclinical atherosclerosis: A recommended update to the editorial policy at Atherosclerosis75
EPA and DHA differentially modulate monocyte inflammatory response in subjects with chronic inflammation in part via plasma specialized pro-resolving lipid mediators: A randomized, double-blind, cross74
Trends in lipid-modifying agent use in 83 countries68
Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective68
Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill?64
Epicardial fat and coronary artery disease: Role of cardiac imaging62
Non-genetic influences on lipoprotein(a) concentrations59
Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors58
The accuracy of toe brachial index and ankle brachial index in the diagnosis of lower limb peripheral arterial disease: A systematic review and meta-analysis56
Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial53
Transendothelial transport of lipoproteins53
Lipoprotein(a) levels from childhood to adulthood: Data in nearly 3,000 children who visited a pediatric lipid clinic51
Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK51
Shift work, and particularly permanent night shifts, promote dyslipidaemia: A systematic review and meta-analysis51
Lipoprotein(a) and ethnicities48
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?48
HDAC3 protects against atherosclerosis through inhibition of inflammation via the microRNA-19b/PPARγ/NF-κB axis48
Existing and emerging strategies to lower Lipoprotein(a)47
Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen General Population Study47
Cardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule46
South Asian ethnicity as a risk factor for coronary heart disease45
Brain-heart connections in stress and cardiovascular disease: Implications for the cardiac patient45
Lipoprotein (a) and diabetes mellitus44
Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies42
Marked plaque regression in homozygous familial hypercholesterolemia42
Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis42
The multifaceted impact of complement on atherosclerosis42
Prognostic value of coronary artery calcium score, area, and density among individuals on statin therapy vs. non-users: The coronary artery calcium consortium41
Lipoprotein(a): An underestimated inflammatory mastermind41
Oxidized phospholipid modification of lipoprotein(a): Epidemiology, biochemistry and pathophysiology39
Multifaceted role of extracellular vesicles in atherosclerosis39
Machine learning integration of circulating and imaging biomarkers for explainable patient-specific prediction of cardiac events: A prospective study39
Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis38
Blood urea nitrogen, blood urea nitrogen to creatinine ratio and incident stroke: The Dongfeng-Tongji cohort38
0.022372007369995